Propriétés allergiques et activatrices de MRGPRX2 des médicaments : vers un algorithme mécanistique résolutif
- 9 July 2024
- journal article
- research article
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 64 (5)
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Mast cell activation test in chlorhexidine allergy: a proof of conceptBritish Journal of Anaesthesia, 2020
- Application of specific-to-total IgE ratio does not benefit diagnostic performance of serologic testing for rocuronium allergyBritish Journal of Anaesthesia, 2020
- Measurement and Functional Analysis of the Mas-Related G Protein-Coupled Receptor MRGPRX2 on Human Mast Cells and Basophils2020
- MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo‐allergic and anaphylactoid reactionsPharmacology Research & Perspectives, 2019
- Serum Tryptase Cannot Differentiate Vancomycin-Induced Anaphylaxis From Red Man SyndromeJournal of Clinical Immunology, 2019
- Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendationsBritish Journal of Anaesthesia, 2019
- IgE‐mediated allergy to pholcodine and cross‐reactivity to neuromuscular blocking agents: Lessons from flow cytometryCytometry Part B: Clinical Cytometry, 2013
- Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgeryEuropean Journal of Clinical Pharmacology, 2007
- Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptorsBiochemical and Biophysical Research Communications, 2006
- The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanylCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1991